Position in XENE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$9,820,572
+$650,317 QoQ
Shares Held
162,700
+3.2% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#92
of 314 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. XENE ranks #36 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in XENE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,820,572 | 162,700 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,170,255 | 157,700 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $5,109,480 | 114,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $5,074,960 | 126,400 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,890,590 | 124,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,213,880 | 125,600 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,962,720 | 126,600 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,933,061 | 125,300 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $4,916,639 | 126,100 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,329,590 | 123,800 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,702,228 | 123,800 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,815,672 | 111,700 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,227,300 | 109,800 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,625,527 | 101,300 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,443,761 | 112,700 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,913,240 | 108,400 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,279,276 | 107,800 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,980,575 | 97,500 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,730,376 | 87,400 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $968,752 | 63,400 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,152,578 | 61,900 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,145,600 | 64,000 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $961,250 | 62,500 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $691,875 | 62,500 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $783,750 | 62,500 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||